Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Kamb

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Nature Biotechnology|November 12, 2013
Human genetics as a foundation for innovative drug developmentAlexander Kamb, Sean Harper, Kari Stefansson
Journal of Biotechnology|August 2, 2003
Functional analysis of expressed peptides that bind yeast STE proteinsGiordano Caponigro, Majid Abedi, Alexander Kamb
Nature Reviews. Drug Discovery|December 13, 2006
Why is cancer drug discovery so difficult?Alexander Kamb, Susan Wee, Christoph Lengauer
International Journal of Cancer|September 2, 2003
Overexpression of the beta-catenin binding domain of cadherin selectively kills colorectal cancer cellsMichael Pierce, Chunwei Wang, Mark Stump, et al.
Clinical Immunology (Orlando, Fla.)|May 13, 2022
The Tmod cellular logic gate as a solution for tumor-selective immunotherapyBreanna DiAndreth, Agnes E Hamburger, Han Xu, et al.
Frontiers in Immunology|April 1, 2022
Robust <i>In Vitro</i> Pharmacology of Tmod, a Synthetic Dual-Signal Integrator for Cancer Cell TherapyDiane Manry, Kristian Bolanos, Breanna DiAndreth, et al.
Journal of Biotechnology|June 8, 2002
Enhanced expression of exogenous genes from retroviruses using HIV2/TatRobert W Sandrock, Isaac Peterson, Cameron Evans, et al.
Journal of Biomolecular Screening|July 15, 2003
A high-throughput, homogeneous microplate assay for agents that kill mammalian tissue culture cellsMichael Pierce, Chunwei Wang, Matt Rebentisch, et al.
Journal of Biomolecular Screening|July 5, 2002
An automated system for screening retroviral expression constructs in microplate formatMark D Stump, Leonardo Di Sera, Matthew Rebentisch, et al.
Immunohorizons|May 27, 2021
Design of TCR Structural Variants That Retain or Invert the Normal Activation SignalJee-Young Mock, Julyun Oh, Jason Yi, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Nature Biotechnology|November 12, 2013
Human genetics as a foundation for innovative drug developmentAlexander Kamb, Sean Harper, Kari Stefansson
Journal of Biotechnology|August 2, 2003
Functional analysis of expressed peptides that bind yeast STE proteinsGiordano Caponigro, Majid Abedi, Alexander Kamb
Nature Reviews. Drug Discovery|December 13, 2006
Why is cancer drug discovery so difficult?Alexander Kamb, Susan Wee, Christoph Lengauer
International Journal of Cancer|September 2, 2003
Overexpression of the beta-catenin binding domain of cadherin selectively kills colorectal cancer cellsMichael Pierce, Chunwei Wang, Mark Stump, et al.
Clinical Immunology (Orlando, Fla.)|May 13, 2022
The Tmod cellular logic gate as a solution for tumor-selective immunotherapyBreanna DiAndreth, Agnes E Hamburger, Han Xu, et al.
Frontiers in Immunology|April 1, 2022
Robust <i>In Vitro</i> Pharmacology of Tmod, a Synthetic Dual-Signal Integrator for Cancer Cell TherapyDiane Manry, Kristian Bolanos, Breanna DiAndreth, et al.
Journal of Biotechnology|June 8, 2002
Enhanced expression of exogenous genes from retroviruses using HIV2/TatRobert W Sandrock, Isaac Peterson, Cameron Evans, et al.
Journal of Biomolecular Screening|July 15, 2003
A high-throughput, homogeneous microplate assay for agents that kill mammalian tissue culture cellsMichael Pierce, Chunwei Wang, Matt Rebentisch, et al.
Journal of Biomolecular Screening|July 5, 2002
An automated system for screening retroviral expression constructs in microplate formatMark D Stump, Leonardo Di Sera, Matthew Rebentisch, et al.
Immunohorizons|May 27, 2021
Design of TCR Structural Variants That Retain or Invert the Normal Activation SignalJee-Young Mock, Julyun Oh, Jason Yi, et al.
Pageof 5